Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations
Eesha Chitneni, Adwaith Venugopal, Confidence Obianuju Okorie, Annie T George, Aakriti Arya, Domenica Arias, Omar Yasin, Livia Cereser Prado de Souza, Roshan Afshan, Vyapti A Dave · 2026
Read Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations by Eesha Chitneni, Adwaith Venugopal, Confidence Obianuju Okorie, Annie T George, Aakriti Arya, Domenica Arias, Omar Yasin, Livia Cereser Prado de Souza, Roshan Afshan, Vyapti A Dave (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13235695.txt.
Description
Eesha Chitneni and co-authors review precision drugs that strike lung cancer's driver mutations in work dated two thousand twenty-six. Lung cancer leads cancer deaths worldwide, and its common form, non-small cell, often runs on one faulty growth gene. Drugs built to block those exact proteins now rival chemotherapy.
Three weapon types lead: small blocking molecules, lab-made antibodies, and antibody-drug pairs that ferry poison to the cell. Targets include the EGFR, ALK, KRAS, and ROS1 genes plus immune checkpoint paths. Trial data show better outcomes for matched patients. Side effects and the cancer's knack for resistance remain the twin hurdles. The review weighs each drug class by target and evidence.
Catalog record
| CREATOR | Eesha Chitneni, Adwaith Venugopal, Confidence Obianuju Okorie, Annie T George, Aakriti Arya, Domenica Arias, Omar Yasin, Livia Cereser Prado de Souza, Roshan Afshan, Vyapti A Dave |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |